Cookies helfen uns bei der Bereitstellung unserer Dienste. Durch die Nutzung unserer Dienste erklären Sie sich damit einverstanden, dass wir Cookies setzen.
De En Es
Kundenservice: +49 (0) 551 - 547 24 0

Cuvillier Verlag

30 Jahre Kompetenz im wissenschaftlichen Publizieren
Internationaler Fachverlag für Wissenschaft und Wirtschaft

Cuvillier Verlag

Premiumpartner
De En Es
Titelbild-leitlinien
Predicting Oral Absorption of Poorly Soluble Weakly Basic Drugs

Printausgabe
EUR 52,90

E-Book
EUR 37,03

Predicting Oral Absorption of Poorly Soluble Weakly Basic Drugs

Mark Berlin (Autor)

Vorschau

Inhaltsverzeichnis, PDF (60 KB)
Leseprobe, PDF (260 KB)

ISBN-13 (Printausgabe) 9783736991460
ISBN-13 (E-Book) 9783736981461
Sprache Englisch
Seitenanzahl 248
Umschlagkaschierung matt
Auflage 1. Aufl.
Erscheinungsort Göttingen
Promotionsort Frankfurt am Main
Erscheinungsdatum 08.12.2015
Allgemeine Einordnung Dissertation
Fachbereiche Pharmzeutische Technologie
Schlagwörter Weak base, Dissolution, Supersaturation, Precipitation, Gastric emptying, Food effects, IVIVC, PBPK modeling
Beschreibung

This book deals with predicting behavior of poorly soluble weakly basic drugs in the human body, particularly in the gastrointestinal tract. Under fasting conditions weak bases usually show good solubility in the human stomach and poor solubility in the intestine. This solubility discrepancy can lead to unusual drug dissolution behavior during the process of gastric emptying, such as supersaturation and precipitation. The current thesis investigates dissolution, supersaturation and precipitation behavior of weak bases in the human stomach and intestine using biorelevant media. These media simulate fluids of the gastrointestinal tract and can be utilized in different in vitro experiments mimicking the human gastric and intestinal physiology. The experimental outcomes can then be coupled with physiologically based pharmacokinetic (PBPK) models, which simulate drug uptake into the human blood flow and finally enable the prediction of drug plasma concentration profiles in humans. This work shows that combining biorelevant in vitro investigation with PBPK modeling is essential for predicting in vivo performance of poorly soluble weakly basic drugs.